Company / Current Liabilities per Share
Ernexa Therapeutics Inc. Current Liabilities per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.91
FY2025
5-year range
$0.54 / $2.12
FY2021-FY2025
Trend
+67.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.06 in FY2015 to $3.59 in FY2016.
Based on SEC 10-K filings.
0.91 in FY2025 with a 10-year CAGR of +32.3%.
Improved from $1.28 to $0.91 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +2.2%
- 10-Year CAGR
- +32.3%
Key checks
Key Insights
- In FY2025, current liabilities per share increased 67.3% year-over-year.
- Peak current liabilities per share was recorded in FY2016.
- Lowest current liabilities per share in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.91 | +67.3% |
| FY2024 | $0.54 | -57.6% |
| FY2023 | $1.28 | +57.6% |
| FY2020 | $0.81 | -61.6% |
| FY2019 | $2.12 | +32.8% |
| FY2018 | $1.60 | +1272.9% |
| FY2017 | $0.12 | -96.8% |
| FY2016 | $3.59 | +6379.2% |
| FY2015 | $0.06 | -38.5% |
| FY2014 | $0.09 | +77.8% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026